An asian study to assess the properties and profile of ticagrelor in Patients with Stable Coronary Artery Disease

Study identifier:D5130C00065

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomised, Double-Blind, Parallel Group, Asian, Multicenter Study, to Assess Pharmacokinetic and Pharmacodynamic Profile of 2 Doses of Ticagrelor on Top of Low Dose Acetyl Salicylic Acid (ASA) Therapy on Platelet Aggregation in Japanese and Asian Patients with Stable Coronary Artery Disease

Medical condition

Stable coronary artery disease

Phase

Phase 2

Healthy volunteers

No

Study drug

ticagrelor, clopidogrel

Sex

All

Actual Enrollment

146

Study type

Interventional

Age

20 Years - 80 Years

Date

Study Start Date: 01 Apr 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics/dynamics Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Jun 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria